Australia markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.45-0.03 (-0.55%)
At close: 04:00PM EDT
5.38 -0.07 (-1.28%)
After hours: 04:08PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.86-0.85-2.92-2.98
Low estimate-1.21-1.17-4.77-4.94
High estimate-0.7-0.7-2.21-0.77
Year ago EPS-1.3-1.43-5.81-2.92
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate720k720k2.36M32.08M
Low estimateN/AN/AN/AN/A
High estimate1.8M1.8M5.3M130.4M
Year ago salesN/A3.76M9.94M2.36M
Sales growth (year/est)N/A-80.90%-76.20%1,259.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.13-1.14-1.14-0.87
Actual EPS-1.3-1.43-2.18-0.1
Difference-0.17-0.29-1.040.77
Surprise %-15.00%-25.40%-91.20%88.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.86-0.85-2.92-2.98
7 days ago-0.91-0.91-3.69-3.34
30 days ago-0.91-0.91-3.69-3.34
60 days ago-1.05-0.99-4.11-3.08
90 days ago-1.05-0.99-4.11-3.08
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2242
Up last 30 days2242
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/A1
Growth estimatesSYRSIndustrySector(s)S&P 500
Current qtr.33.80%N/AN/AN/A
Next qtr.40.60%N/AN/AN/A
Current year49.70%N/AN/AN/A
Next year-2.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A